本专刊征集关于药品定价、可及性以及卫生技术评估(HTA)在医疗体系中作用的相关研究。随着药品价格的持续攀升,深入理解创新、可负担性与可及性之间的关系愈发关键。本专刊旨在探讨HTA方法学、定价与报销策略、真实世界证据以及公平性问题,同时涵盖精准医疗与个体化医疗领域所面临的挑战。
This Collection invites research on pharmaceutical pricing, access, and the role of Health Technology Assessment (HTA) in healthcare. As medicine prices rise, understanding links between innovation, affordability, and access is key. It explores HTA methods, pricing and reimbursement strategies, real‑world evidence, and equity, including challenges in precision and personalised medicine.